Watch for the IPO pricing announcement, expected within 1-2 days. The concurrent $100M private placement from AbbVie provides a strong strategic endorsement. Monitor first-day trading volume and price action for initial demand signals.
Price Chart
Executive Summary
The SEC declared effective ADARx Pharmaceuticals' S-1 registration statement for its initial public offering of 21,875,000 shares of common stock, with an expected price range of $15.00 to $17.00 per share. The company will begin trading on Nasdaq under the ticker ADRX, and pricing is expected within 1-2 days. This is a transformative event, providing the company with its first public market access and proceeds to fund its clinical pipeline.
Key Facts
- IPO of 21,875,000 shares of common stock declared effective by SEC on September 24, 2026.
- Expected IPO price range: $15.00 to $17.00 per share.
- Underwriters granted a 30-day option to purchase up to 3,281,250 additional shares.
- AbbVie Inc. agreed to purchase shares in a concurrent private placement, owning approximately 4.9% of outstanding shares post-offering, capped at $100.0 million.
- Listing on The Nasdaq Global Select Market under symbol ADRX.
- Lead underwriters: J.P. Morgan, Morgan Stanley, TD Cowen, UBS Investment Bank, LifeSci Capital.
Financial Impact
Gross proceeds to the company before expenses estimated between $328.1 million and $371.9 million at the midpoint of the price range, plus up to $49.2 million to $55.8 million from the overallotment option.
Risk Factors
- IPO pricing below the expected range could signal weak demand.
- Post-IPO lock-up expiration (typically 180 days) could lead to selling pressure.
- Clinical-stage biotech with no approved products; pipeline execution risk.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-003052 |
| Document: 9999999995-26-003052-index.html | 9999999995-26-003052 |
| Document: 9999999995-26-003052.txt | 9999999995-26-003052 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 9d ago | SC 13G | $17.63 $17.68 | ▲ +0.28% | ▼ −0.05% | $17.63 (−0.00%) |
Oct 5, 2026 20d ago | SC 13D | $18.58 $17.33 | ▼ −6.73% | ▼ −6.49% | $17.63 (−5.11%) |
Oct 2, 2026 23d ago | SC 13D | $19.05 $18.58 | ▼ −2.47% | ▼ −3.02% | $17.63 (−7.45%) |
Oct 1, 2026 24d ago | Press Release | $18.25 $19.05 | ▲ +4.38% | ▲ +3.71% | $17.63 (−3.40%) |
Oct 1, 2026 24d ago | SC 13G | $18.25 $19.05 | ▲ +4.38% | ▲ +3.71% | $17.63 (−3.40%) |
Sep 30, 2026 25d ago | Insider Cluster | $19.54 $18.25 | ▼ −6.60% | ▼ −7.34% | $17.63 (−9.77%) |
Sep 29, 2026 26d ago | Insider Cluster | $19.94 $19.54 | ▼ −2.01% | ▼ −2.18% | $17.63 (−11.58%) |
Sep 29, 2026 26d ago | Insider Buy | $19.94 $19.54 | ▼ −2.01% | ▼ −2.18% | $17.63 (−11.58%) |
Sep 25, 2026 4w ago | 424B4 | $20.09 $20.64 | ▲ +2.71% | ▲ +2.90% | $17.63 (−12.24%) |
Sep 25, 2026 4w ago | EFFECT | $19.35 $20.09 | ▲ +3.82% | ▲ +4.57% | $17.63 (−8.89%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers